Advances in technology and research are continually improving cancer monitoring. The development of more sensitive and specific biomarkers and less invasive testing methods, like liquid biopsies, promises to enhance the accuracy and ease of monitoring. Personalized medicine approaches, which tailor monitoring and treatment to the individual characteristics of each patient's cancer, are also on the rise.
